Last: | $ |
---|---|
Change Percent: | 0.92% |
Open: | $48.20 |
Close: | $48.42 |
High: | $48.42 |
Low: | $48.19 |
Volume: | 4,677 |
Last Trade Date Time: | 01/01/2020 04:13:47 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $48.20 | $48.42 | $48.42 | $48.19 | 4,677 | 01-01-2020 |
$ | $48.20 | $48.42 | $48.42 | $48.19 | 4,677 | 12-31-2019 |
$ | $48.1242 | $48.0046 | $48.1242 | $47.9117 | 1,693 | 12-30-2019 |
$ | $48.18 | $48.18 | $48.18 | $48.18 | 513 | 12-27-2019 |
$ | $47.78 | $47.73 | $47.90 | $47.73 | 2,144 | 12-26-2019 |
$ | $47.42 | $47.69 | $47.77 | $47.42 | 1,621 | 12-25-2019 |
$ | $47.42 | $47.69 | $47.77 | $47.42 | 1,621 | 12-24-2019 |
$ | $47.87 | $47.5448 | $47.87 | $47.5448 | 4,039 | 12-23-2019 |
$ | $47.6715 | $47.6921 | $47.7356 | $47.6715 | 2,107 | 12-20-2019 |
$ | $47.2256 | $47.31 | $47.3799 | $47.2256 | 4,499 | 12-19-2019 |
$ | $47.4992 | $47.62 | $47.62 | $47.39 | 5,832 | 12-18-2019 |
$ | $47.5798 | $47.6239 | $47.6239 | $47.5798 | 321 | 12-17-2019 |
$ | $47.68 | $47.88 | $47.88 | $47.55 | 1,652 | 12-16-2019 |
$ | $47.35 | $47.40 | $47.40 | $47.0979 | 4,653 | 12-13-2019 |
$ | $48.01 | $47.49 | $48.01 | $47.32 | 24,539 | 12-12-2019 |
$ | $48.094 | $47.86 | $48.1108 | $47.86 | 1,075 | 12-11-2019 |
$ | $48.175 | $48.21 | $48.21 | $48.1557 | 1,122 | 12-10-2019 |
$ | $48.2752 | $48.375 | $48.488 | $48.2752 | 1,057 | 12-09-2019 |
$ | $48.2701 | $48.375 | $48.4119 | $48.2701 | 1,418 | 12-06-2019 |
$ | $48.0663 | $48.075 | $48.075 | $48.0663 | 412 | 12-05-2019 |
News, Short Squeeze, Breakout and More Instantly...
Cohen & Steers Global Realty Majors Company Name:
GRI Stock Symbol:
NYSE Market:
Cohen & Steers Global Realty Majors Website:
LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune di...
Live webcast on Wednesday, May 1 st at 3:00 PM ET LA JOLLA, CA, April 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell mo...
Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation Continued advancement of an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases LA JOLL...